These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6219291)

  • 41. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
    Porter KG; Sinnamon DG; Gillies RR
    Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice.
    Turcotte R
    Infect Immun; 1981 Nov; 34(2):315-22. PubMed ID: 6458564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-mediated immunity in Cryptococcosis.
    Graybill JR; Alford RH
    Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
    [No Abstract]   [Full Text] [Related]  

  • 44. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunity.
    Shourian M; Flaczyk A; Angers I; Mindt BC; Fritz JH; Qureshi ST
    Infect Immun; 2015 Dec; 83(12):4541-54. PubMed ID: 26371125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice.
    Fromtling RA; Fromtling AM; Staib F; Müller S
    Infect Immun; 1981 Jun; 32(3):1073-8. PubMed ID: 7251157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis.
    Blackstock R; Hall NK; Hernandez NC
    Infect Immun; 1989 Jun; 57(6):1773-9. PubMed ID: 2656522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).
    Lacroix C; Chau F; Carbon C; Sinet M; Derouin F
    Clin Exp Immunol; 1997 Nov; 110(2):196-202. PubMed ID: 9367402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans.
    Qureshi MH; Zhang T; Koguchi Y; Nakashima K; Okamura H; Kurimoto M; Kawakami K
    Eur J Immunol; 1999 Feb; 29(2):643-9. PubMed ID: 10064081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.
    Huffnagle GB; Yates JL; Lipscomb MF
    J Exp Med; 1991 Apr; 173(4):793-800. PubMed ID: 1672543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background.
    Surawut S; Makjaroen J; Thim-Uam A; Wongphoom J; Palaga T; Pisitkun P; Chindamporn A; Leelahavanichkul A
    J Microbiol; 2019 Jan; 57(1):45-53. PubMed ID: 30456753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fever of unknown origin and cryptococcal antigen].
    Torroba Alvarez L; Fortún Abete J; Buzón Rueda L; Moreno Caparrós A
    Med Clin (Barc); 1988 Oct; 91(13):514. PubMed ID: 3067009
    [No Abstract]   [Full Text] [Related]  

  • 53. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.
    Mody CH; Chen GH; Jackson C; Curtis JL; Toews GB
    J Lab Clin Med; 1993 Jun; 121(6):765-73. PubMed ID: 7685044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro binding of natural killer cells to Cryptococcus neoformans targets.
    Nabavi N; Murphy JW
    Infect Immun; 1985 Oct; 50(1):50-7. PubMed ID: 3899938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
    Wormley FL; Perfect JR; Steele C; Cox GM
    Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B cell response during infection with the MAT a and MAT alpha mating types of Cryptococcus neoformans.
    Rodrigues AR; Heise N; Previato JO; Mendonça-Previato L; Peçanha LM
    Microbes Infect; 2005 Jan; 7(1):118-25. PubMed ID: 15716070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary cryptococcosis in the rat.
    Graybill JR; Ahrens J; Nealon T; Paque R
    Am Rev Respir Dis; 1983 May; 127(5):636-40. PubMed ID: 6342482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered responsiveness of murine lymphoid cells treated with cryptococcal capsular polysaccharide.
    Lee I; Vogel F; Breen J; Friedman H
    Proc Soc Exp Biol Med; 1982 Apr; 169(4):427-31. PubMed ID: 7041127
    [No Abstract]   [Full Text] [Related]  

  • 59. Resistance to Cryptococcus neoformans infection in the absence of CD4+ T cells.
    Aguirre K; Crowe J; Haas A; Smith J
    Med Mycol; 2004 Feb; 42(1):15-25. PubMed ID: 14982110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection.
    Gyetko MR; Sud S; Chen GH; Fuller JA; Chensue SW; Toews GB
    J Immunol; 2002 Jan; 168(2):801-9. PubMed ID: 11777975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.